FONR Q1 2025 Earnings Profitability Maintained Amid Limited Disclosure Odysightai Inc ODYS Q1 2026 Earnings EPS Miss but Positive Stock Reaction Signals Investor Confidence MARPS Q4 2025 Earnings Trust Reports Positive EPS Despite Sparse Data Stock Gains 142 Seneca Foods Q1 2026 Earnings Strong EPS of 619 Despite Modest Stock Reaction Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development